From Elsevier Business Intelligence
Including company and deal data plus articles from publications like IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

Sanofi-Aventis

www.sanofi-aventis.com

Most Recent Related Deals

Sanofi launches $69 per share bid for Genzyme; $17.5bn value, 8/2010
Sanofi, JDRF sign Type I diabetes agreement, 7/2010
Sanofi gets cancer compounds from Ascenta, Univ. of MI, 6/2010
Sanofi Pasteur gets rights to Humalex platform from Vivalis, 6/2010
Sanofi and Regulus enter microRNA deal valued at over $750mm, 6/2010
Metabolex grants Sanofi rights to Phase II diabetes candidate, 6/2010
Sanofi pays $75mm now for TargeGen; could pay $485mm more, 6/2010
Sanofi gets rights to Glenmark's TRPV3 antagonists for pain, 5/2010
Sanofi to buy Nepentes for €105mm, 5/2010
Sanofi and Nichi-Iko form generics joint venture, 5/2010

Most Recent Related Articles

Click an article to see a free preview (15 of 801).

Silenor Deal Gives P&G Easy Access To Rx Market, Possible OTC Sales, The Tan Sheet 8/2010
Business News, In Brief, The Pink Sheet 8/2010
Deals Of The Week: Roche/BioImagene, P&G/Somaxon, Roche/Aileron ..., The Pink Sheet 8/2010
Court Backs FDA Rationale For Approving Generic Lovenox, The Pink Sheet 8/2010
DotW Talks Pickles, The IN VIVO Blog 8/2010
Lilly To Cease Development Of Alzheimer's Drug: A Blow To The Amyloid Hypothesis?, The Pink Sheet 8/2010
Business News In Brief, The Pink Sheet 8/2010
Perrigo's Generic Mucinex Becomes A Long Shot To Launch In Fiscal 2011, The Tan Sheet 8/2010
Inequitable Conduct: Drug Industry Implores Federal Circuit To Revise Standard For Finding Deception In Patent Prosecution, The Pink Sheet 8/2010
Business News, In Brief, The Pink Sheet 8/2010
Earnings In Brief, The Pink Sheet 8/2010
Deals of the Week Waits for the Bear Hug, The IN VIVO Blog 7/2010
Glenmark May Shelve Research On Metabolic Disorders, Trim TRPV1 Pipeline And Take A Bigger Exposure To Biologics, PharmAsia News 7/2010
National Advertising Division In Brief, The Tan Sheet 7/2010
Failed Drug Candidates Getting Re-Screened By EPA To Find Toxicity Markers, The Pink Sheet 7/2010

See all 801 articles about this company

Copyright © 2009 Elsevier Inc. All rights reserved. Elsevier Business Intelligence, www.ElsevierBI.com.
Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com.